CID 3065034

N-(4-((6-phenylimidazo(2,1-b)thiazol-3(2h)-ylidene)amino)phenyl)acetamide

Structural Information

Molecular Formula
C19H16N4OS
SMILES
CC(=O)NC1=CC=C(C=C1)N=C2CSC3=NC(=CN23)C4=CC=CC=C4
InChI
InChI=1S/C19H16N4OS/c1-13(24)20-15-7-9-16(10-8-15)21-18-12-25-19-22-17(11-23(18)19)14-5-3-2-4-6-14/h2-11H,12H2,1H3,(H,20,24)
InChIKey
XGLPOOUHXZTTOM-UHFFFAOYSA-N
Compound name
N-[4-[(6-phenylimidazo[2,1-b][1,3]thiazol-3-ylidene)amino]phenyl]acetamide
Related CIDs

2D Structure

compound 2d structure
1
Annotation Hits

0
References

0
Patents

348.1045 Da
Monoisotopic Mass

3.2
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 349.11178 179.6
[M+Na]+ 371.09372 191.9
[M+NH4]+ 366.13832 188.0
[M+K]+ 387.06766 185.8
[M-H]- 347.09722 186.0
[M+Na-2H]- 369.07917 188.0
[M]+ 348.10395 183.5
[M]- 348.10505 183.5
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

No literature data available for this compound.

Patent stripe

No patent data available for this compound.